Abcam
Abcam plc, commonly known as Abcam, is a leading life sciences company headquartered in Cambridge, GB. Founded in 1998, Abcam has established itself as a prominent player in the biotechnology industry, specialising in the production and distribution of high-quality antibodies and related products. With a strong focus on research and development, the company serves a global market, with significant operations across Europe, North America, and Asia. Abcam's core offerings include a vast range of antibodies, proteins, and assays, which are renowned for their specificity and reliability. The company’s commitment to innovation and quality has positioned it as a trusted partner for researchers in academia and industry alike. Notable achievements include a robust portfolio of over one million products, making Abcam a go-to resource for scientists seeking advanced tools for their research.
DitchCarbon Score
How does Abcam's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Abcam's score of 52 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Abcam's reported carbon emissions
In 2022, Abcam's carbon emissions in Great Britain totalled approximately 659,000 kg CO2e, comprising 289,000 kg CO2e from Scope 1 and 370,000 kg CO2e from Scope 2. This represents a significant reduction from 2021, when emissions were about 1,272,000 kg CO2e (494,000 kg CO2e from Scope 1 and 778,000 kg CO2e from Scope 2). Globally, Abcam reported total emissions of approximately 102,263,000 kg CO2e in 2022, with Scope 1 emissions at 1,224,000 kg CO2e, Scope 2 at 3,370,000 kg CO2e, and Scope 3 emissions at 97,669,000 kg CO2e. This data reflects a comprehensive approach to emissions reporting, including all three scopes. Abcam has not publicly disclosed specific reduction targets or initiatives through the Science Based Targets initiative (SBTi) or other climate pledges. The emissions data is cascaded from its parent company, Danaher Corporation, indicating a corporate commitment to sustainability at multiple levels. Overall, Abcam's emissions data highlights a proactive stance in managing carbon footprints, with a clear focus on reducing Scope 1 and 2 emissions in the UK while also addressing global emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 1,554,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 3,198,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 4,752,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Abcam is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
